|
GCC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43780551301143E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.75339997655311E-09 |
| Normal-vs-Stage2 |
6.94659999522784E-08 |
| Normal-vs-Stage3 |
2.05150008092403E-10 |
| Normal-vs-Stage4 |
1.56830004538477E-09 |
| Stage1-vs-Stage2 |
2.160800E-01 |
| Stage1-vs-Stage3 |
1.697960E-01 |
| Stage1-vs-Stage4 |
9.182400E-02 |
| Stage2-vs-Stage3 |
8.101200E-01 |
| Stage2-vs-Stage4 |
7.369200E-01 |
| Stage3-vs-Stage4 |
5.115200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12140313596387E-11 |
| Normal-vs-AfricanAmerican |
6.116400E-03 |
| Normal-vs-Asian |
2.15339999998232E-06 |
| Caucasian-vs-AfricanAmerican |
1.701590E-01 |
| Caucasian-vs-Asian |
6.618600E-01 |
| AfricanAmerican-vs-Asian |
3.726800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.77968792217598E-12 |
| Normal-vs-Female |
9.74829994504489E-10 |
| Male-vs-Female |
1.445200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02520000044848E-07 |
| Normal-vs-Age(41-60Yrs) |
1.73279945947513E-10 |
| Normal-vs-Age(61-80Yrs) |
8.07560018856179E-10 |
| Normal-vs-Age(81-100Yrs) |
4.818400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.411200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.055990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.763600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.837000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.536800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.196640E-01 |
| Classical-VS-Follicular |
2.415700E-02 |
| Classical-VS-Other |
8.609500E-02 |
| Classical-VS-Normal |
5.5380999786081E-09 |
| Tall-VS-Follicular |
9.749400E-01 |
| Tall-VS-Other |
3.278600E-01 |
| Tall-VS-Normal |
3.46899999947858E-07 |
| Follicular-VS-Other |
4.261400E-01 |
| Follicular-VS-Normal |
8.25650003921652E-09 |
| Other-VS-Normal |
3.198200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.93469750909526E-11 |
| Normal-vs-N1 |
2.7138999936227E-09 |
| N0-vs-N1 |
2.843800E-01 |
|
|
